Apoptosis in Barrett's oesophagus following antireflux surgery

The British journal of surgery

Volumn 89, Issue 11, 2002, Pages 1444-1449

  Chen, L Q ^a   Hu, C Y ^c   Der Sarkissian, S ^b   Ferraro, P ^a   Pera, M ^d   deBlois, D ^b   Gaboury, L ^a   Duranceau, A C ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; BIOPSY; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HUMAN; INFANT; INTESTINE MUCOSA; METHODOLOGY; NEWBORN; NICK END LABELING; PATHOLOGY; PRESCHOOL CHILD;

APOPTOSIS; BARRETT ESOPHAGUS; BIOPSY; CHILD, PRESCHOOL; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HUMANS; IN SITU NICK-END LABELING; INFANT; INFANT, NEWBORN; INTESTINAL MUCOSA;

EID: 0036833465     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2002.02229.x     Document Type: Article

References (32)

1. 1 Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population‐based study in Olmsted County, Minnesota. Gastroenterology 1997 ; 112: 1448–56.
2. 2 Spechler SJ, Goyal RK. The columnar‐lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996 ; 110: 614–21.
3. 3 Sarr MG, Hamilton SR, Marrone GC, Cameron JL. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Am J Surg 1985 ; 149: 187–93.
4. 4 Bonelli L. Barrett's esophagus: results of a multicentric survey. GOSPE (Gruppo Operativo per lo Studio delle Precancerosi Esofagee). Endoscopy 1993 ; 25: 652–4.
5. 5 Haggitt RC. Barrett's esophagus, dysplasia, and adeno carcinoma. Hum Pathol 1994 ; 25: 982–93.
6. 6 Cameron AJ. Epidemiology of columnar‐lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997 ; 26: 487–94.
7. 7 Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol 1999 ; 26 (Suppl 15): 2–8.
8. 8 Pera M. Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction. Recent Results Cancer Res 2000 ; 155: 1–14.
9. 9 Rabinovitch PS, Reid BJ, Haggitt RC, Norwood TH, Rubin CE. Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest 1989 ; 60: 65–71.
10. 10 Reid BJ. Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am 1991 ; 20: 817–34.
11. 11 Ransford RA, Jankowski JA. Genetic versus environmental interactions in the oesophagitis–metaplasia–dysplasia–adeno carcinoma sequence (MCS) of Barrett's oesophagus. Acta Gastroenterol Belg 2000 ; 63: 18–21.
12. 12 Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994 ; 107: 3569–77.
13. 13 King KL, Cidlowski JA. Cell cycle regulation and apoptosis. Annu Rev Physiol 1998 ; 60: 601–17.
14. 14 Cohen JJ. Apoptosis. Immunol Today 1993 ; 14: 126–30.
15. 15 Martin SJ, Green DR. Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit Rev Oncol Hematol 1995 ; 18: 137–53.
16. 16 Chen LQ, Hu CY, Gaboury L, Pera M, Ferraro P, Duranceau AC. Proliferative activity in Barrett's esophagus before and after antireflux surgery. Ann Surg 2001 ; 234: 172–80.
17. 17 Chen LQ, Nastos D, Hu CY, Chughtai TS, Taillefer R, Ferraro P et al. Results of the Collis–Nissen gastroplasty in patients with Barrett's esophagus. Ann Thorac Surg 1999 ; 68: 1014–21.
18. 18 Lauwers GY, Kandemir O, Kubilis PS, Scott GV. Cellular kinetics in Barrett's epithelium carcinogenic sequence: roles of apoptosis, bcl‐2 protein, and cellular proliferation. Mod Pathol 1997 ; 10: 1201–8.
19. 19 Whittles CE, Biddlestone LR, Burton A, Barr H, Jankowski JA, Warner PJ et al. Apoptotic and proliferative activity in the neoplastic progression of Barrett's oesophagus: a comparative study. J Pathol 1999 ; 187: 535–40.
20. 20 Gray MR, Hall PA, Nash J, Ansari B, Lane DP, Kingsnorth AN. Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. Gastroenterology 1992 ; 103: 1769–76.
21. 21 Peters FT, Ganesh S, Kuipers EJ, de Jager‐Krikken A, Karrenbeld A, Harms G et al. Epithelial cell proliferative activity of Barrett's esophagus: methodology and correlation with traditional cancer risk markers. Dig Dis Sci 1998 ; 43: 1501–6.
22. 22 Halm U, Tannapfel A, Breitung B, Marx C, Breidert M, Mossner J. Apoptosis is decreased during the metaplasia–dys plasia–carcinoma sequence in Barrett's esophagus. Gastroenterology 1997 ; 112: A574 (Abstract).
23. 23 Katada N, Hinder RA, Smyrk TC, Hirabayashi N, Perdikis G, Lund RJ et al. Apoptosis is inhibited early in the dys plasia–carcinoma sequence of Barrett esophagus. Arch Surg 1997 ; 132: 728–33.
24. 24 Wetscher GJ, Schwelberger H, Unger A, Offner FA, Profanter C, Glaser K et al. Reflux‐induced apoptosis of the esophageal mucosa is inhibited in Barrett's epithelium. Am J Surg 1998 ; 176: 569–73.
25. 25 Younes M, Lechago J, Ertan A, Finnie D, Younes A. Decreased expression of Fas (CD95/APO1) associated with goblet cell metaplasia in Barrett's esophagus. Hum Pathol 2000 ; 31: 434–8.
26. 26 Campomenosi P, Conio M, Bogliolo M, Urbini S, Assereto P, Aprile A et al. p53 is frequently mutated in Barrett's metaplasia of the intestinal type. Cancer Epidemiol Biomarkers Prev 1996 ; 5: 559–65.
27. 27 Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 1998 ; 93: 536–41.
28. 28 McCallum RW, Polepalle S, Davenport K, Frierson H, Boyd S. Role of antireflex surgery against dysplasia in Barrett's esophagus. Gastroenterology 1991 ; 100: A121 (Abstract).
29. 29 Martin CJ, Cox MR, Cade RJ. Collis–Nissen gastroplasty fundoplication for complicated gastro‐oesophageal reflux disease. Aust N Z J Surg 1992 ; 62: 126–9.
30. 30 Fitzgerald RC, Omary MB, Triadafilopoulos G. Altered sodium–hydrogen exchange activity is a mechanism for acid‐induced hyperproliferation in Barrett's esophagus. Am J Physiol 1998 ; 275: G47–55.
31. 31 van Nieuwenhove Y, Willems G. Gastroesophageal reflux triggers proliferative activity of the submucosal glands in the canine esophagus. Dis Esophagus 1998 ; 11: 89–93.
32. 32 Souza RF, Shewmake K, Terada LS, Spechler SJ. Acid exposure activates the mitogen‐activated protein kinase pathways in Barrett's esophagus. Gastroenterology 2002 ; 122: 299–307.